Delivery Order SPE2DB20D1050-SPE2DB25FH81E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with a ceiling value of $1,421.78. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, under a firm fixed-price contract structure with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,701.77 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order, awarded on September 4, 2025, represents a non-competitive set-aside award under the company's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $2,350.40 to AmerisourceBergen Drug Corp for the supply of Valacyclovir HCL 1 Gram tablets (90-count) under a firm fixed price contract. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,848.18 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,589.52 for Valacyclovir HCl 1 gram tablets (90-count packaging) on June 12, 2025, with completion scheduled for June 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with a ceiling value of $1,359.47 under a firm fixed price contract type. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a non-set-aside competitive award, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,592.05 to AmerisourceBergen Drug Corp for Valacyclovir HCL 500 mg tablets (90-count) on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through an open procurement process. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valacyclovir HCL 1 gram tablets (90-count units) under a firm fixed-price contract valued at $8,724.37. The order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its...
- The Defense Logistics Agency awarded a $3,422.09 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Valacyclovir HCL 1 gram tablets (90-count units). This is a non-set-aside competitive award with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Valacyclovir HCL 1 gram tablets (90-count) with a ceiling value of $1,118.80. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH81EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Valacyclovir HCL 1 gram, valued at $2,358.55 under a firm fixed price contract type. The award, effective July 31, 2025, with an ultimate completion date of August 1, 2025, was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the contract at its Corporate Office location and serve as the prime contractor for this pharmaceutical delivery. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This prime vendor contract functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. The Defense Logistics Agency is currently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/31/25 |